Solar Keratoses Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: S18E218D3D92EN
Market Monitor Global

Abstracts

Solar keratoses are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.

This report contains market size and forecasts of Solar Keratoses Treatment in Global, including the following market information:

Global Solar Keratoses Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Solar Keratoses Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Solar Keratoses Treatment include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera and Almirall and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Solar Keratoses Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Solar Keratoses Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Solar Keratoses Treatment Market Segment Percentages, by Type, 2021 (%)

• Topical Medications
• Photodynamic Therapy
• Destructive Treatment

Global Solar Keratoses Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Solar Keratoses Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Solar Keratoses Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Solar Keratoses Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Solar Keratoses Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Solar Keratoses Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• DUSA Pharmaceuticals
• Novartis
• Perrigo
• LEO Pharma
• Bausch Health
• Taro Pharmaceutical
• Galderma (Nestle)
• Biofrontera
• Almirall
• Tolmar Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Solar Keratoses Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Solar Keratoses Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SOLAR KERATOSES TREATMENT OVERALL MARKET SIZE

2.1 Global Solar Keratoses Treatment Market Size: 2021 VS 2028
2.2 Global Solar Keratoses Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Solar Keratoses Treatment Players in Global Market
3.2 Top Global Solar Keratoses Treatment Companies Ranked by Revenue
3.3 Global Solar Keratoses Treatment Revenue by Companies
3.4 Top 3 and Top 5 Solar Keratoses Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Solar Keratoses Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Solar Keratoses Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Solar Keratoses Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Solar Keratoses Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Solar Keratoses Treatment Market Size Markets, 2021 & 2028
  4.1.2 Topical Medications
  4.1.3 Photodynamic Therapy
  4.1.4 Destructive Treatment
4.2 By Type - Global Solar Keratoses Treatment Revenue & Forecasts
  4.2.1 By Type - Global Solar Keratoses Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Solar Keratoses Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Solar Keratoses Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Solar Keratoses Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Other
5.2 By Application - Global Solar Keratoses Treatment Revenue & Forecasts
  5.2.1 By Application - Global Solar Keratoses Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Solar Keratoses Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Solar Keratoses Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Solar Keratoses Treatment Market Size, 2021 & 2028
6.2 By Region - Global Solar Keratoses Treatment Revenue & Forecasts
  6.2.1 By Region - Global Solar Keratoses Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Solar Keratoses Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Solar Keratoses Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Solar Keratoses Treatment Revenue, 2017-2028
  6.3.2 US Solar Keratoses Treatment Market Size, 2017-2028
  6.3.3 Canada Solar Keratoses Treatment Market Size, 2017-2028
  6.3.4 Mexico Solar Keratoses Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Solar Keratoses Treatment Revenue, 2017-2028
  6.4.2 Germany Solar Keratoses Treatment Market Size, 2017-2028
  6.4.3 France Solar Keratoses Treatment Market Size, 2017-2028
  6.4.4 U.K. Solar Keratoses Treatment Market Size, 2017-2028
  6.4.5 Italy Solar Keratoses Treatment Market Size, 2017-2028
  6.4.6 Russia Solar Keratoses Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Solar Keratoses Treatment Market Size, 2017-2028
  6.4.8 Benelux Solar Keratoses Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Solar Keratoses Treatment Revenue, 2017-2028
  6.5.2 China Solar Keratoses Treatment Market Size, 2017-2028
  6.5.3 Japan Solar Keratoses Treatment Market Size, 2017-2028
  6.5.4 South Korea Solar Keratoses Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Solar Keratoses Treatment Market Size, 2017-2028
  6.5.6 India Solar Keratoses Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Solar Keratoses Treatment Revenue, 2017-2028
  6.6.2 Brazil Solar Keratoses Treatment Market Size, 2017-2028
  6.6.3 Argentina Solar Keratoses Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Solar Keratoses Treatment Revenue, 2017-2028
  6.7.2 Turkey Solar Keratoses Treatment Market Size, 2017-2028
  6.7.3 Israel Solar Keratoses Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Solar Keratoses Treatment Market Size, 2017-2028
  6.7.5 UAE Solar Keratoses Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 DUSA Pharmaceuticals
  7.1.1 DUSA Pharmaceuticals Corporate Summary
  7.1.2 DUSA Pharmaceuticals Business Overview
  7.1.3 DUSA Pharmaceuticals Solar Keratoses Treatment Major Product Offerings
  7.1.4 DUSA Pharmaceuticals Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.1.5 DUSA Pharmaceuticals Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Solar Keratoses Treatment Major Product Offerings
  7.2.4 Novartis Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Perrigo
  7.3.1 Perrigo Corporate Summary
  7.3.2 Perrigo Business Overview
  7.3.3 Perrigo Solar Keratoses Treatment Major Product Offerings
  7.3.4 Perrigo Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.3.5 Perrigo Key News
7.4 LEO Pharma
  7.4.1 LEO Pharma Corporate Summary
  7.4.2 LEO Pharma Business Overview
  7.4.3 LEO Pharma Solar Keratoses Treatment Major Product Offerings
  7.4.4 LEO Pharma Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.4.5 LEO Pharma Key News
7.5 Bausch Health
  7.5.1 Bausch Health Corporate Summary
  7.5.2 Bausch Health Business Overview
  7.5.3 Bausch Health Solar Keratoses Treatment Major Product Offerings
  7.5.4 Bausch Health Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bausch Health Key News
7.6 Taro Pharmaceutical
  7.6.1 Taro Pharmaceutical Corporate Summary
  7.6.2 Taro Pharmaceutical Business Overview
  7.6.3 Taro Pharmaceutical Solar Keratoses Treatment Major Product Offerings
  7.6.4 Taro Pharmaceutical Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.6.5 Taro Pharmaceutical Key News
7.7 Galderma (Nestle)
  7.7.1 Galderma (Nestle) Corporate Summary
  7.7.2 Galderma (Nestle) Business Overview
  7.7.3 Galderma (Nestle) Solar Keratoses Treatment Major Product Offerings
  7.7.4 Galderma (Nestle) Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.7.5 Galderma (Nestle) Key News
7.8 Biofrontera
  7.8.1 Biofrontera Corporate Summary
  7.8.2 Biofrontera Business Overview
  7.8.3 Biofrontera Solar Keratoses Treatment Major Product Offerings
  7.8.4 Biofrontera Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.8.5 Biofrontera Key News
7.9 Almirall
  7.9.1 Almirall Corporate Summary
  7.9.2 Almirall Business Overview
  7.9.3 Almirall Solar Keratoses Treatment Major Product Offerings
  7.9.4 Almirall Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.9.5 Almirall Key News
7.10 Tolmar Pharmaceutical
  7.10.1 Tolmar Pharmaceutical Corporate Summary
  7.10.2 Tolmar Pharmaceutical Business Overview
  7.10.3 Tolmar Pharmaceutical Solar Keratoses Treatment Major Product Offerings
  7.10.4 Tolmar Pharmaceutical Solar Keratoses Treatment Revenue in Global Market (2017-2022)
  7.10.5 Tolmar Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Solar Keratoses Treatment Market Opportunities & Trends in Global Market
Table 2. Solar Keratoses Treatment Market Drivers in Global Market
Table 3. Solar Keratoses Treatment Market Restraints in Global Market
Table 4. Key Players of Solar Keratoses Treatment in Global Market
Table 5. Top Solar Keratoses Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Solar Keratoses Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Solar Keratoses Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Solar Keratoses Treatment Product Type
Table 9. List of Global Tier 1 Solar Keratoses Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Solar Keratoses Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Solar Keratoses Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Solar Keratoses Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Solar Keratoses Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Solar Keratoses Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Solar Keratoses Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Solar Keratoses Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Solar Keratoses Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Solar Keratoses Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Solar Keratoses Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Solar Keratoses Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Solar Keratoses Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Solar Keratoses Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Solar Keratoses Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Solar Keratoses Treatment Revenue, (US$, Mn), 2023-2028
Table 30. DUSA Pharmaceuticals Corporate Summary
Table 31. DUSA Pharmaceuticals Solar Keratoses Treatment Product Offerings
Table 32. DUSA Pharmaceuticals Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Solar Keratoses Treatment Product Offerings
Table 35. Novartis Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Perrigo Corporate Summary
Table 37. Perrigo Solar Keratoses Treatment Product Offerings
Table 38. Perrigo Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 39. LEO Pharma Corporate Summary
Table 40. LEO Pharma Solar Keratoses Treatment Product Offerings
Table 41. LEO Pharma Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Solar Keratoses Treatment Product Offerings
Table 44. Bausch Health Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Taro Pharmaceutical Corporate Summary
Table 46. Taro Pharmaceutical Solar Keratoses Treatment Product Offerings
Table 47. Taro Pharmaceutical Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Galderma (Nestle) Corporate Summary
Table 49. Galderma (Nestle) Solar Keratoses Treatment Product Offerings
Table 50. Galderma (Nestle) Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Biofrontera Corporate Summary
Table 52. Biofrontera Solar Keratoses Treatment Product Offerings
Table 53. Biofrontera Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Almirall Corporate Summary
Table 55. Almirall Solar Keratoses Treatment Product Offerings
Table 56. Almirall Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Tolmar Pharmaceutical Corporate Summary
Table 58. Tolmar Pharmaceutical Solar Keratoses Treatment Product Offerings
Table 59. Tolmar Pharmaceutical Solar Keratoses Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Solar Keratoses Treatment Segment by Type in 2021
Figure 2. Solar Keratoses Treatment Segment by Application in 2021
Figure 3. Global Solar Keratoses Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Solar Keratoses Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Solar Keratoses Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Solar Keratoses Treatment Revenue in 2021
Figure 8. By Type - Global Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 12. US Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 24. China Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Solar Keratoses Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Solar Keratoses Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. DUSA Pharmaceuticals Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Perrigo Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LEO Pharma Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Taro Pharmaceutical Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Galderma (Nestle) Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biofrontera Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Almirall Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Tolmar Pharmaceutical Solar Keratoses Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)